packageBevacizumab

bevacizumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Bevacizumab is a monoclonal antibody that blocks tumour blood vessel growth and is used to treat many cancers, including colorectal, breast, lung, kidney, cervical and ovarian cancers, as well as certain eye conditions such as wet macular degeneration. It is widely used and authorised in the European Union, appears on the WHO list of essential medicines, and is also used off-label in ophthalmology.

Summary written by glm-5.3-flash from Wikidata Q413299 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:bevacizumab
ATC codes:L01FG01, L01XC07, S01LA08
DrugBank:DB00112
Wikidata:Q413299
molar mass:149000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown